RE: ACCUSTEM21 Oct 2020 14:05
Calm down Whimax Chairman’s words are that a fairer more appropriate valuation for Stemprimer would be better served through a demerger and separate listing. Meaning at present he sees little value placed in TILS SP for Stem, Yet a leading US Analyst values Stem around $300M
Yes Stem may get sold it may not.